These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 26569655)

  • 21. [Adherence to Long-term Follow-up in Paediatric Oncology--Results of a Monocentric Analysis].
    Welsch S; Hense HW; Groll A; Fröhlich B; Goletz G; Wältermann M; Jürgens H
    Klin Padiatr; 2015 May; 227(3):144-50. PubMed ID: 25811744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Issues of loss to follow-up in a population study of traumatic brain injury (TBI) followed to 3 years post-trauma.
    Langley J; Johnson S; Slatyer M; Skilbeck CE; Thomas M
    Brain Inj; 2010; 24(7-8):939-47. PubMed ID: 20545449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of informed consent requirements on cardiac arrest research in the United States: exception from consent or from research?
    Nichol G; Huszti E; Rokosh J; Dumbrell A; McGowan J; Becker L
    Resuscitation; 2004 Jul; 62(1):3-23. PubMed ID: 15246579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On clinical trial fragility due to patients lost to follow up.
    Baer BR; Fremes SE; Gaudino M; Charlson M; Wells MT
    BMC Med Res Methodol; 2021 Nov; 21(1):254. PubMed ID: 34800976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Strategies to reduce patient loss during the follow-up period of randomized trials].
    Uhlig A
    Urologe A; 2018 May; 57(5):601-604. PubMed ID: 29651710
    [No Abstract]   [Full Text] [Related]  

  • 27. Predictors of follow-up completeness in longitudinal research on traumatic brain injury: findings from the National Institute on Disability and Rehabilitation Research traumatic brain injury model systems program.
    Krellman JW; Kolakowsky-Hayner SA; Spielman L; Dijkers M; Hammond FM; Bogner J; Hart T; Cantor JB; Tsaousides T
    Arch Phys Med Rehabil; 2014 Apr; 95(4):633-41. PubMed ID: 24211496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Participant retention in clinical trials of candidate HIV vaccines.
    de Bruyn G; Hudgens MG; Sullivan PS; Duerr AC
    J Acquir Immune Defic Syndr; 2005 Aug; 39(4):499-501. PubMed ID: 16010176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attrition and retention of ethnically diverse subjects in a multicenter randomized controlled research trial.
    Janson SL; Alioto ME; Boushey HA;
    Control Clin Trials; 2001 Dec; 22(6 Suppl):236S-43S. PubMed ID: 11728627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Registry Studies Use Inconsistent Methods to Account for Patients Lost to Follow-up, and Rates of Patients LTFU Are High.
    Vemulapalli KV; Sunil Kumar KH; Khanduja V
    Arthrosc Sports Med Rehabil; 2021 Dec; 3(6):e1607-e1619. PubMed ID: 34977612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dropouts and sub-groups--statistics can help but not cure.
    Croft P; Froud R; Lewis AM
    Pain; 2010 Dec; 151(3):563-564. PubMed ID: 20832943
    [No Abstract]   [Full Text] [Related]  

  • 32. Participation and retention can be high in randomized controlled trials targeting underserved populations: a systematic review and meta-analysis.
    Ojha RP; Jackson BE; Lu Y; Burton M; Blair SE; MacDonald BR; Chu TC; Teigen KJ; Acosta M
    J Clin Epidemiol; 2018 Jun; 98():154-157. PubMed ID: 29183689
    [No Abstract]   [Full Text] [Related]  

  • 33. Data retention after a patient withdraws consent in clinical trials.
    Gabriel AP; Mercado CP
    Open Access J Clin Trials; 2011 Apr; 3():15-19. PubMed ID: 23935390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Submitting the original participant information letter as supplementary material of a trial report is useful and can be easily implemented.
    Kotz D; Viechtbauer W; Spigt M; Crutzen R
    J Clin Epidemiol; 2020 Jan; 117():151-153. PubMed ID: 31542506
    [No Abstract]   [Full Text] [Related]  

  • 35. Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
    Rao MP; Halvorsen S; Wojdyla D; Thomas L; Alexander JH; Hylek EM; Hanna M; Bahit MC; Lopes RD; De Caterina R; Erol C; Goto S; Lanas F; Lewis BS; Husted S; Gersh BJ; Wallentin L; Granger CB;
    J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26627878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality Tolerance Limits: Framework for Successful Implementation in Clinical Development.
    Bhagat R; Bojarski L; Chevalier S; Görtz DR; Le Meignen S; Makowski M; Nadolny P; Pillwein M; Suprin M; Turri S
    Ther Innov Regul Sci; 2021 Mar; 55(2):251-261. PubMed ID: 32885397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lost to Follow-up and Withdrawal of Consent in Contemporary Global Cardiovascular Randomized Clinical Trials.
    Rodriguez F; Harrison RW; Wojdyla D; Mahaffey KW
    Crit Pathw Cardiol; 2015 Dec; 14(4):150-3. PubMed ID: 26569655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bias and Loss to Follow-Up in Cardiovascular Randomized Trials: A Systematic Review.
    Fong LCW; Ford TJ; da Costa BR; Jüni P; Berry C
    J Am Heart Assoc; 2020 Jul; 9(14):e015361. PubMed ID: 32646264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reporting of Lost to Follow-Up and Treatment Discontinuation in Pharmacotherapy and Device Trials in Chronic Heart Failure: A Systematic Review.
    Campbell RT; Willox GP; Jhund PS; Hawkins NM; Huang F; Petrie MC; McMurray JJ
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27162229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review.
    Akl EA; Briel M; You JJ; Sun X; Johnston BC; Busse JW; Mulla S; Lamontagne F; Bassler D; Vera C; Alshurafa M; Katsios CM; Zhou Q; Cukierman-Yaffe T; Gangji A; Mills EJ; Walter SD; Cook DJ; Schünemann HJ; Altman DG; Guyatt GH
    BMJ; 2012 May; 344():e2809. PubMed ID: 22611167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.